You have no items in your shopping cart.
On Promotion
Category
Tested Applications
Reactivity
Conjugation
Biologically Active
Featured Product
Search results for: 'recombinant'
Unconjugated
SDS-PAGE: Greater than 95% as determined by reducing SDS-PAGE.
Predicted: 62.6 KDa. Observed: 80-90 KDa, reducing conditions
Human
Gln32-Leu360
C-mIgG2a Fc
10 μg, 50 μg, 500 μg, 1 mgUnconjugated
SDS-PAGE: Greater than 95% as determined by reducing SDS-PAGE.
Predicted: 39.9 KDa. Observed: 50-80 KDa, reducing conditions
Human
Ser21-Glu359
C-6His
10 μg, 50 μg, 500 μg, 1 mgUnconjugated
SDS-PAGE: Greater than 95% as determined by reducing SDS-PAGE.
Predicted: 49.1 KDa. Observed: 55-60 KDa, reducing conditions
Human
(YMLDLQPET)&Ile21-Met119&Gly25-Ile308 (Ala269Val)
C-10His
10 μg, 1 mg, 50 μg, 500 μgUnconjugated
SDS-PAGE: Greater than 95% as determined by reducing SDS-PAGE.
Predicted: 49.1 KDa. Observed: 55-60 KDa, reducing conditions
Human
(RMFPNAPYL)&Ile21-Met119&Gly25-Ile308 (Ala269Val)
C-10His
10 μg, 50 μg, 500 μg, 1 mgUnconjugated
SDS-PAGE: Greater than 95% as determined by reducing SDS-PAGE.
Predicted: 64.8 KDa. Observed: 90-120 KDa, reducing conditions
Human
Phe19-Lys379
C-mFc
10 μg, 500 μg, 50 μg, 1 mgBiotin
SDS-PAGE: Greater than 95% as determined by reducing SDS-PAGE.
Predicted: 19.1 KDa. Observed: 25-35 KDa, reducing conditions
Human
Ala28-Pro172
C-6His-Avi
20 μg, 100 μgBiotin
SDS-PAGE: Greater than 95% as determined by reducing SDS-PAGE.
Predicted: 28.4 KDa. Observed: 35-50 KDa, reducing conditions
Human
Thr32-His266
C-Avi-6His
20 μg, 100 μgUnconjugated
SDS-PAGE: Greater than 95% as determined by reducing SDS-PAGE.
Predicted: 8.6 KDa. Observed: 9 KDa, reducing conditions
Human
Met1-Gly76
Tag free
10 μg, 50 μg, 500 μg, 1 mgUnconjugated
SDS-PAGE: Greater than 95% as determined by reducing SDS-PAGE.
Predicted: 85.6 KDa. Observed: 85-110 KDa, reducing conditions
Human
Met18-Pro540
C-Fc
10 μg, 500 μg, 50 μg, 1 mgUnconjugated
SDS-PAGE: Greater than 95% as determined by reducing SDS-PAGE.
Predicted: 83.3 KDa. Observed: 90-100 KDa, reducing conditions
Human
Gln18-Gly540
C-Fc
10 μg, 50 μg, 500 μg, 1 mg